The present results suggest that abnormal activation of the PI3K/Akt pathway caused by EphA2 over-expression is part of the mechanism underlying the EphA2-mediated paclitaxel resistance in NPC cells. Here, EPHA2 is linked to nasopharyngeal carcinoma.